Changes in Circulating Plasma Volume as a Marker of Dry Weight in Chronic Hemodialyzed Patients.

Nihon Toseki Igakkai Zasshi
doi 10.4009/jsdt.32.1051
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society for Dialysis Therapy

Related search

Fructosamine Concentration in Serum and Plasma of Hemodialyzed Patients With Chronic Renal Failure

Journal of Japanese Society for Dialysis Therapy
1989English

Can Plasma BNP Serve as a Factor Predicting Cardiovascular Events in Hemodialyzed Patients?

Nihon Toseki Igakkai Zasshi
1997English

Assessment of Body Fluid Component in Hemodialyzed Patients Using a Body Composition Analyzer(InBody S20):Can the Bioelectrical Impedance Method Be a Marker of Dry Weight?

Nihon Toseki Igakkai Zasshi
2007English

Mean Platelet Volume as a Fibrosis Marker in Patients With Chronic Hepatitis C

Afro-Egyptian Journal of Infectious and Endemic Diseases
2014English

Band 3 Profile as a Marker of Erythrocyte Changes in Chronic Kidney Disease Patients

The Open Clinical Chemistry Journal
2008English

Spleen Size in Hemodialyzed Patients

Journal of Japanese Society for Dialysis Therapy
1989English

Plasma Epstein-Barr Virus DNA as an Archetypal Circulating Tumour DNA Marker

Journal of Pathology
Forensic MedicinePathology
2019English

Circulating Ki-67 Index in Plasma as a Biomarker and Prognostic Indicator in Chronic Lymphocytic Leukemia

Leukemia Research
Cancer ResearchOncologyHematology
2010English

Circulating miR-1826 in Plasma Correlates With Circulating Tumor Cells and Is a Prognostic Marker in Colorectal Cancer

Tumor Biology
MedicineCancer Research
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy